1. Home
  2. PCRX vs APC Comparison

PCRX vs APC Comparison

Compare PCRX & APC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$25.17

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo ARKO Petroleum Corp. Class A Common Stock

APC

ARKO Petroleum Corp. Class A Common Stock

N/A

Current Price

$15.77

Market Cap

892.9M

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
PCRX
APC
Founded
2006
2025
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil Refining/Marketing
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
892.9M
IPO Year
2010
2025

Fundamental Metrics

Financial Performance
Metric
PCRX
APC
Price
$25.17
$15.77
Analyst Decision
Buy
Strong Buy
Analyst Count
9
4
Target Price
★ $30.00
$22.25
AVG Volume (30 Days)
★ 464.2K
131.5K
Earning Date
11-05-2026
11-13-2026
Dividend Yield
N/A
★ 12.90%
EPS Growth
★ 107.44
N/A
EPS
0.19
★ 0.46
Revenue
★ $541,533,000.00
N/A
Revenue This Year
$3.85
$14.55
Revenue Next Year
$4.69
N/A
P/E Ratio
$131.63
★ $32.67
Revenue Growth
★ 26.04
N/A
52 Week Low
$18.80
$14.50
52 Week High
$27.66
$21.72

Technical Indicators

Market Signals
Indicator
PCRX
APC
Relative Strength Index (RSI) 49.83 35.33
Support Level $24.61 N/A
Resistance Level $25.17 $19.35
Average True Range (ATR) 0.81 0.74
MACD 0.03 -0.25
Stochastic Oscillator 68.40 30.15

Price Performance

Historical Comparison
PCRX
APC

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About APC ARKO Petroleum Corp. Class A Common Stock

Arko Petroleum Corp is a fuel distribution company. It operates through three reportable segments: i) Wholesale: Distributes fuel to gas stations, sub-wholesalers, and bulk purchasers, typically under long-term contracts on a cost-plus or consignment basis. ii) Fleet Fueling: Operates proprietary and third-party cardlock locations serving commercial and municipal fleets, and earns commissions from proprietary fuel card sales. iii) GPMP: Supplies fuel to ARKO Retail Sites at cost plus a fixed margin, charges fixed fees to certain sites. The company generates the majority of revenue from the Wholesale segment.

Share on Social Networks: